ChemoTech’s Animal Care division signs Letter of Intent with a prominent player in the North American veterinary market
Scandinavian ChemoTech can gladly state that its subsidiary Vetiqure AB is close to securing a very impactful distribution agreement with Avante Animal Health in the United States.The Letter of Intent (LOI) clearly outlines a very detailed arrangement for a planned distribution agreement. It also specifies the aim to install approximately six vetIQure™ systems at various university hospitals and leading clinics, which are already clients of Avante Animal Health. These systems are to be installed at the end of 2022 and then undergo an evaluation period for 3 months at each designated